miRNA engineering of CHO cells facilitates production of difficult‐to‐express proteins and increases success in cell line development

In recent years, coherent with growing biologics portfolios also the number of complex and thus difficult‐to‐express (DTE) therapeutic proteins has increased considerably. DTE proteins challenge bioprocess development and can include various therapeutic protein formats such as monoclonal antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Simon, Marquart, Kim F., Pieper, Lisa A., Fieder, Juergen, Gamer, Martin, Gorr, Ingo, Schulz, Patrick, Bradl, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084326/
https://www.ncbi.nlm.nih.gov/pubmed/28262952
http://dx.doi.org/10.1002/bit.26280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084326/
https://www.ncbi.nlm.nih.gov/pubmed/28262952
http://dx.doi.org/10.1002/bit.26280

Ejemplares similares